When was Signos founded?

Signos was founded in 2020 and raised its 1st funding round 1 year after it was founded.

Where is Signos located?

Signos is headquartered in San Francisco, United States.

Who is the current CEO of Signos?

Sharam Fouladgar-Mercer of Signos. They have also founded 1 company.

How many employees does Signos have?

As of Jun 30, 2026, the latest employee count at Signos is 105.

Is Signos a funded company?

Signos is a funded company, having raised a total of $57M across 4 funding rounds to date. The company's 1st funding round was a $***** Seed round, raised on Jan 2021.

When was the latest funding round of Signos?

Signos' latest funding was a $***** Series B round on May 27, 2026, with participation from 2 investors. Its primary sector is Disease Self Management. In United States, the Disease Self Management sector has seen $733M in funding in 2026 to date.

Where does Signos rank among its competitors?

Signos ranks 4th amongst 292 active competitors, of which 76 are funded. It stands 6th in terms of total funding among its competitors. The most recent competitor to raise funding was Signos, which secured $20M in May, 2026.

Who are the top competitors of Signos?

Signos' top competitors include Dexcom, Insulet and Senseonics. Among them, Signos secured the most recent funding round in May, 2026.

Signos - 2026 Company Profile, Team, Funding & Competitors

Company Details

Provider of a wearable device for blood glucose pattern monitoring. The company has developed an app-based platform that recommends meals and exercises for users based on the glucose pattern detected through the connected device. The app provides real-time glucose monitoring and glucose spike levels for different foods. Based on this, personalized fitness and nutrition plan can be developed.

Website: www.signos.com/
Social
Email ID: *****@signos.com

Key Metrics

Founded Year

2020

Location

San Francisco, United States

Stage

Series B

Total Funding

$57M in 4 rounds

Latest Funding Round

Series B, May 27, 2026, $*****

Investors

Google Ventures & 15 more

Ranked

4^th among 292 active competitors

Employee Count

105 as on Jun 30, 2026

Similar Companies

Dexcom & 429 more

View Signos' full profile

Signos has raised a total funding of $57M over 4 rounds. Its first funding round was on Jan 2021. Its latest funding round was a Series B round on May 27, 2026 for $*****. 2 investors participated in its latest round. Signos has 13 institutional investors and 3 angel investors.

Here is the list of recent funding rounds of Signos:

Filter this list

Date of Funding	Funding Amount	Round Name	Post-Money Valuation	Revenue Multiple	Lead Investors	Other Investors
May 27, 2026	3801328	Series B	6674291	4368927	2147499	9354788
Oct 24, 2023	8054510	Series B	7155184	1936565	8136926	Dexcom Ventures & 1 more
Nov 10, 2021	6134351	Series A	9581898	4361648	Google Ventures	Courtside Ventures & 6 more

Access funding benchmarks and valuations. Sign up today!

View details of Signos's funding rounds and investors

The founders of Signos are William Dixon and Sharam Fouladgar-Mercer. Sharam Fouladgar-Mercer is the CEO of Signos.

Here are the details of Signos' key team members:

William Dixon: Co-Founder of Signos.
Contact Info: 1 email address
Sharam Fouladgar-Mercer: Co-Founder & CEO of Signos and founder of 1 other company.

View details of Signos's Founder profiles and Board Members

Signos' employee count trend

Signos has 105 employees as of Jun 26. Here is Signos's employee count trend over the years:

Uncover Signos' growth story! Sign up today!

Access Tracxn on any website

Our Google Chrome extension lets you view company details while browsing their websites

Install Tracxn Extension

Top competitors of Signos include Dexcom, Insulet and Senseonics. Here is the list of Top 10 competitors of Signos, ranked by Tracxn score:

Rank	Company Details	Short Description	Total Funding	Investors	Tracxn Score
1st	Dexcom 1999, San Diego (United States), Public	Provider of a wearable device for glucose monitoring	$52.7M	Invesco Mutual Fund, Lucas Venture Group & 7 others	79/100
2nd	Insulet 2000, Boston (United States), Public	Manufacturer of wearable, tubeless insulin delivery systems for diabetes management	$120M	Federated Hermes, Piper Jaffray & 13 others	74/100
3rd	Senseonics 1996, Germantown (United States), Public	Provider of implantable systems for continuous glucose monitoring	$165M	New Enterprise Associates, Greenspring Associates ... & 9 others	71/100
4th	Signos 2020, San Francisco (United States), Series B	Provider of a wearable device for blood glucose pattern monitoring	$57M	Cheyenne Ventures, Google Ventures & 14 others	70/100
5th	mySugr 2012, Vienna (Austria), Acquired	Gamification apps for diabetes management and therapy	$4.8M	iSeed Ventures, Roche & 7 others	70/100
6th	Livongo 2014, San Francisco (United States), Acquired	Provider of smart devices for diabetes management for patients and doctors	$245M	General Catalyst, Kinnevik & 21 others	69/100
7th	sugar.fit 2021, Bengaluru (India), Series A	Provider of diabetes care and reversal programs	$26.7M	B Capital, MassMutual Ventures & 16 others	68/100
8th	Jana Care 2011, Newton (United States), Series C	Provider of mobile-based healthcare diagnostics for diabetes prevention	$35.7M	IAG Capital Partners, MK Energy & 16 others	63/100
9th	Liom 2017, Pfaffikon (Switzerland), Series A	Platform offering non invasive glucose monitoring solutions	$79.3M	Ornament, Daniel Gutenberg & 11 others	63/100
10th	Levels 2019, United States, Series A	Provider of wearable device for personalized insights into metabolic health	$67M	TriplePoint Capital, Trust Ventures & 36 others	60/100